Vitamin D supplementation and central adiposity in male shift workers: a randomized clinical trial on metabolic health
Randomized controlled trialMachine-checked Sep 21, 2026AI-assisted draft
Menezes-Júnior L et al. Vitamin D supplementation and central adiposity in male shift workers: a randomized clinical trial on metabolic health. Sao Paulo medical journal = Revista paulista de medicina, 2026. PubMed 42659412 · DOI
- Design
- Randomized, double-blind, placebo-controlled clinical trial.
- Population
- 198 male shift workers at an iron ore extraction company in Minas Gerais, Brazil, with 25(OH)D concentrations under 30 ng/mL and at least one metabolic abnormality (metabolic syndrome, impaired fasting glucose, dyslipidemia, elevated blood pressure, or increased waist circumference).
- Intervention
- Cholecalciferol (vitamin D3) supplementation versus placebo.
- Dose as studied
- 14,000 IU/week or 28,000 IU/week.
- Comparator
- Placebo.
- Duration
- 4 months.
Outcomes, as reported
- Waist circumference (WC) No significant difference between either vitamin D dose group and placebo after 4 months.
- Waist-to-height ratio (WHtR) No significant difference between either vitamin D dose group and placebo after 4 months (p > 0.05).
- Serum 25(OH)D concentration Increased +6.23 ng/mL (p25=0.58, p75=10.61) in the 14,000 IU/week group and +15.25 ng/mL (p25=10.57, p75=19.68) in the 28,000 IU/week group; placebo group decreased -0.50 ng/mL (p25=-1.03, p75=2.71).
Not stated in the abstract.
Not stated in the abstract.